ABERNETHY MATT Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
29
Insider Sells Sum
$14.96M

Insider Activity of ABERNETHY MATT

According to the SEC Form 4 filings, ABERNETHY MATT, being in a position of

  1. Chief Financial Officer at Neurocrine Biosciences, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 2311 share for $363,285,
    over all time since 2018-12-03, has bought 0 shares, and sold 127562 shares for $15.33M.

Biography of ABERNETHY MATT

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $363,2851100

Comparison of Insiders on Amount of Buys and Sells

2026-09-14SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
2,311
0.0023%
$157.20$363,285-9.32%
2025-02-13SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
2,558
0.0025%
$116.86$298,923+14.2%
2025-02-10SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
980
0.0009%
$118.27$115,909+12.24%
2025-01-31SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
1,283
0.0013%
$152.87$196,136-12.38%
2024-08-13SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
14,100
0.0143%
$150.38$2.12M-18.27%
2024-07-16SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
900
0.001%
$150.04$135,037-16.47%
2024-05-15SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
15,000
0.0147%
$140.24$2.1M-11.56%
2024-05-14SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
15,000
0.0146%
$135.66$2.03M-9.23%
2024-02-13SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
1,352
0.0014%
$132.85$179,612+1.56%
2024-02-08SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
980
0.0009%
$134.21$131,529+1.15%
2024-02-06SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
1,280
0.0013%
$142.19$182,000-4.88%
2024-01-31SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
1,283
0.0013%
$140.72$180,539-2.7%
2023-08-21SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
2,132
0.0022%
$107.39$228,958+23.68%
2023-02-08SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
980
0.001%
$104.19$102,110+0.27%
2023-02-07SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
26,328
0.0267%
$102.40$2.7M+0.81%
2023-02-06SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
1,280
0.0013%
$105.67$135,253-0.44%
2023-01-31SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
1,283
0.0013%
$109.98$141,108-5.74%
2022-02-08SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
980
0.001%
$79.65$78,058+28.58%
2022-02-07SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
3,310
0.0035%
$80.79$267,428+26.82%
2021-12-01SaleNeurocrine Biosciences, Inc.
NBIX
Chief Financial Officer
1,645
0.0018%
$82.59$135,852+16.8%
Total: 30
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.